Drug
letrozole and ribociclib
Marketed as KISQALI FEMARA CO-PACK.
Generic name
letrozole and ribociclib
Brand names
KISQALI FEMARA CO-PACK
First FDA approval
2017-05-04
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| NDA209935 | KISQALI FEMARA CO-PACK | 2017-05-04 | NOVARTIS |
Manufacturers
NOVARTIS
Frequently asked questions
When was letrozole and ribociclib FDA approved?
Earliest FDA approval on record: 2017-05-04.
What brand names are sold as letrozole and ribociclib?
KISQALI FEMARA CO-PACK.
Sources
Appeal a letrozole and ribociclib denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com